Skip to main content
Ryvu Therapeutics S.A. (WSE:RVU)
Poland flag Poland · Delayed Price · Currency is PLN
24.10
+0.20 (0.84%)
Apr 29, 2026, 12:47 PM CET

Ryvu Therapeutics Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
5536278901,3291,1391,120
Upgrade
Market Cap Growth
5.75%-29.61%-33.04%16.75%1.70%23.98%
Upgrade
Enterprise Value
5415857551,0821,0981,035
Upgrade
Last Close Price
23.9027.1038.5057.5049.2561.00
Upgrade
PS Ratio
6.307.148.7319.7616.6431.62
Upgrade
PB Ratio
10.2611.645.855.123.326.94
Upgrade
P/TBV Ratio
11.5613.116.175.253.367.08
Upgrade
P/FCF Ratio
----75.58-
Upgrade
P/OCF Ratio
----53.41-
Upgrade
PEG Ratio
-3.413.413.413.413.41
Upgrade
EV/Sales Ratio
6.176.677.4116.0816.0529.21
Upgrade
EV/FCF Ratio
-4.45---72.90-
Upgrade
Debt / Equity Ratio
1.781.780.670.040.040.08
Upgrade
Debt / FCF Ratio
----0.84-
Upgrade
Net Debt / Equity Ratio
-0.22-0.22-0.81-0.86-0.26-0.46
Upgrade
Net Debt / EBITDA Ratio
0.130.131.112.561.541.11
Upgrade
Net Debt / FCF Ratio
0.100.100.922.40-5.961.06
Upgrade
Asset Turnover
0.290.290.260.150.190.14
Upgrade
Inventory Turnover
11.6311.6311.779.069.377.56
Upgrade
Quick Ratio
2.082.082.423.828.092.76
Upgrade
Current Ratio
2.262.262.523.998.212.88
Upgrade
Return on Equity (ROE)
-98.22%-98.22%-54.11%-30.55%-33.20%-41.08%
Upgrade
Return on Assets (ROA)
-20.14%-20.14%-19.50%-13.86%-12.34%-18.80%
Upgrade
Return on Invested Capital (ROIC)
-270.37%-275.62%-380.19%-67.32%-40.89%-101.00%
Upgrade
Return on Capital Employed (ROCE)
-59.70%-59.70%-45.00%-29.20%-16.20%-41.00%
Upgrade
Earnings Yield
-18.32%-16.16%-12.52%-6.93%-7.36%-7.06%
Upgrade
FCF Yield
-22.00%-19.40%-15.21%-7.00%1.32%-6.33%
Upgrade
Buyback Yield / Dilution
---0.97%-24.75%--9.48%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.